Myeloma NZ | Multiple Myeloma

Newsletter: Winter 2022

Aug 22, 2022 | Newsletters

I hope that you are all keeping as well as possible with all these viruses circulating at the moment. I see from some comments on the Facebook page...

Rachel Smalley: 1,000 kiwis will die while Pharmac takes eight months to make a decision

Aug 17, 2022 | Article of the week, Helpful videos, News

OPINION: How long does it take you to make a decision about whether or not to buy something? You’ve got all the information in front of you. You...

Multiple Myeloma Queenstown Summit

Jun 29, 2022 | Article of the week, News, Upcoming events

In August 2022, Myeloma New Zealand is hosting its 4th Myeloma Summit for medical professionals in Queenstown. Held in 2016,2018, 2020 and now again...

Multiple Myeloma Research Review

May 23, 2022 | Article of the week, News, Research, Research Review

Multiple_Myeloma_Research_Review_Issue_42Download

Multiple Myeloma CEO, Dr Ken Romeril, on The AM Show this morning, calling for a release of the independent report on Pharmac

May 11, 2022 | News

Please click on this link to watch the interview: https://fb.watch/cWyMuvV_QO/

DOCTOR CALLS ON MINISTER LITTLE TO RELEASE ‘BURIED’ INDEPENDENT REPORT ON PHARMAC

May 11, 2022 | Article of the week, News

MEDIA RELEASE DOCTOR CALLS ON MINISTER LITTLE TO RELEASE ‘BURIED’ INDEPENDENT REPORT ON PHARMAC The final report of the Independent Pharmac Review...

Dr Ken Romeril, of Wellington, receives his MNZM for services to haematology.

May 4, 2022 | Article of the week, News

Congratulations on your very well-deserved appointment to The New Zealand Order of Merit for your services to Haematology! Dr Ken Romeril is a...

Updates on the Rapidly Changing Therapeutic Landscape in Multiple Myeloma

May 1, 2022 | Article of the week, News

As we continue to understand more about the biology of multiple myeloma (MM) and the number of treatment options for patients with MM continues to...

Multiple Myeloma Media Release

Apr 28, 2022 | Article of the week, News

The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected medicines with substantial clinical benefit...